- Deadline
- May 30, 2029 · 944 days left
- Posted
- Aug 19, 2026
- Award size
- Not listed
- Total program funding
- Not listed
- Expected awards
- Not listed
- Cost sharing
- Not required
- Funding type
- Grant
- Category
- Health
Check this solicitation free
Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.
About this opportunity
The Institutional Development Award (IDeA) program develops biomedical research capacity in states that have historically received low levels of NIH funding (IDeA states). The IDeA Clinical & Translational Research (CTR) program supports two programmatic tracks to build clinical and translational (C&T) research capacity to enable research on diseases and health challenges prevalent in IDeA states. IDeA CTR Development (CTR-D) awards focus on C&T research workforce development and infrastructure enhancement at health research organizations with limited clinical research capacity in IDeA states. IDeA CTR Network (CTR-N) awards support statewide (or multi-state) networks of health research organizations to expand existing infrastructure, develop the research workforce to enhance the network organization's ability to design and implement competitive C&T research programs, and coordinate clinical research activities state-wide and/or across IDeA states.This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.
Who can apply
- Public and state universities
- Other (see eligibility)
- Federally recognized tribal governments
- County governments
- Private universities
- Nonprofits without 501(c)(3) status
- State governments
- City or township governments
- Special district governments
- Independent school districts
- For-profit organizations
- Small businesses
- Other Native American tribal organizations
- Public and Indian housing authorities
- Nonprofits with 501(c)(3) status
Eligibility Criteria for Lead and Partner OrganizationsEvery organization in the application must be either a Lead or a Partner–no organization can be both.Every organization in the application must be in an IDeA-eligible state.There are strict limits to avoid overlap:Each IDeA-eligible state can only have one active IDeA-CTR-type (IDeA-CTR, CTR-N, or CTR-D) award at a time.An organization can only be involved in one IDeA-CTR-type award at a time.Organizations may not serve as a lead, partner or otherwise participate with an active Clinical and Translational Science Award (CTSA). Organizations must meet all eligibility rules at the time of application submission and award.Additional Eligibility Criteria for Lead OrganizationsTo apply as the lead, the organization must:Already have externally-funded clinical and translational (C&T) research.Additional Eligibility Criteria for Partner OrganizationsTo participate as a partner, the organization mustBe in the same state or multi-state region as the lead organization.Note:Active awards include awards in no-cost extension (NCE).An organization that currently leads an active IDeA-CTR-type award may submit a new application if substantial changes to the CTR are proposed. If the new application is funded, the current award will be administratively ended before the new award begins.
Agency contact
NIGMS IDeA CTR
- Reads the full solicitation and lays out every required section
- Drafts each section with you, in your words
- Checks the draft against every requirement before you submit
How to write it
All guidesMore from NIH
All NIH funding- Closes in 1 dayRFA-HG-27-011
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
Deadline Oct 30, 2026(1d)Up to $1.3M
- Closes in 1 dayRFA-HG-27-013
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Deadline Oct 30, 2026(1d)Up to $500K
- Closes in 1 dayRFA-HG-27-012
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Deadline Oct 30, 2026(1d)Up to $2.3M
- Closes in 1 dayPAR-27-045
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
Deadline Oct 30, 2026(1d)
- Closes in 4 daysPAR-24-280
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline Nov 2, 2026(4d)
- Closes in 4 daysPAR-24-279
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline Nov 2, 2026(4d)
Get new funding every Monday
New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.
Details from Grants.gov, last updated Aug 20, 2026. Deadlines and requirements can change: always confirm them in the official notice.